United Therapeutics Corporation
UTHR
$307.24
$1.850.61%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 301.30M | 309.10M | 278.10M | 306.60M | 217.10M |
| Total Depreciation and Amortization | 19.70M | 19.10M | 18.70M | 15.00M | 13.70M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.40M | 36.00M | 44.20M | 15.10M | 11.60M |
| Change in Net Operating Assets | -4.20M | 13.00M | -108.80M | 39.80M | -91.70M |
| Cash from Operations | 341.20M | 377.20M | 232.20M | 376.50M | 150.70M |
| Capital Expenditure | -86.70M | -76.50M | -45.10M | -38.20M | -78.70M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -89.20M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -36.50M | -38.40M | -34.90M | 773.50M | 210.00M |
| Cash from Investing | -123.20M | -114.90M | -80.00M | 735.30M | 42.10M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -100.00M | -100.00M | -100.00M | -100.00M | -100.00M |
| Issuance of Common Stock | 25.60M | 36.30M | 52.10M | 46.10M | 7.30M |
| Repurchase of Common Stock | -300.00K | -400.00K | -100.00K | -1.01B | -100.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | -2.70M | 0.00 |
| Cash from Financing | -74.70M | -64.10M | -48.00M | -1.07B | -92.80M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 143.30M | 198.20M | 104.20M | 43.80M | 100.00M |
